The content is available as a PDF (1.4 MB).
Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB
James L Alexander
Nick Kennedy
Hajir Ibraheim
Sulak Anandabaskaran
Aamir Saifuddin
Rocio Castro Seoane
Zhigang Liu
Rachel Nice
Claire M Bewshea
Andrea D'Mello
Laura E Constable
Gareth-Rhys Jones
Sharmili Balarajah
Francesca Fiorentino
Shaji Sebastian
Peter M Irving
Lucy C Hicks
Horace R Williams
Alexandra J Kent
Miles Parkes
Klaartje Kok
Kamal V Patel
Daniel Altmann
Rosemary Boyton
James Goodhand
Ailsa Hart
Charlie W Lees
Tariq Ahmad
Nick Powell
Issue date 2022 May.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
